Hong Kong stocks are fluctuating, with all innovative pharmaceutical concept stocks falling across the board. The global bond market is witnessing a sell-off trend, with high interest rates potentially impacting industry valuations and financing.

According to the Zhitong Finance and Economics APP, the concept stocks of innovative drugs all fell. As of the end of the report, Keiji Pharmaceutical-B (02171.HK) fell by 6.95% to HK $18.35; Conring Jeri Pharmaceutical-B (09966.HK) fell by 5.27% to HK $8.45; Kai Tak Pharmaceutical-B (09939.HK) fell by 3.47% to HK $2.78; and Tengsheng Bo Pharmaceutical-B (02137) fell by 3.31% to HK $1.17.